Community pharmacies may soon have less control over the prices they charge for OTC medications and other products, thanks to the US Supreme Court's recent ruling legalizing resale price maintenance (RPM) schemes.
These trade restraints' under which suppliers effectively dictate minimum retail prices for their products, have been treated as a federal antitrust law violation for much of the past century. In reversing course, the high court has given manufacturers of drugs, cosmetics, and other products a green light to establish resale prices for their items, and to refuse to sell to discount retailers who are unwilling to honor those minimum price levels.
The Oncology Care Pharmacist in Health-System Pharmacy
According to the National Cancer Institute, almost 40% of men and women will be given a diagnosis of some form of cancer in their lifetime.
News from the year's biggest meetings
Clinical features with downloadable PDFs